Your browser doesn't support javascript.
loading
Novel, natural allosteric inhibitors and enhancers of Candida rugosa lipase activity.
Menden, Ariane; Crynen, Stefan; Mathura, Venkatarian; Paris, Daniel; Crawford, Fiona; Mullan, Michael; Ait-Ghezala, Ghania.
  • Menden A; Roskamp Institute, 2040 Whitfield Ave, Sarasota, FL, 34243, United States; Open University, Walton Hall, Kents Hill, Milton-Keynes MK7 6AA, United Kingdom. Electronic address: amenden@roskampinstitute.org.
  • Crynen S; Roskamp Institute, 2040 Whitfield Ave, Sarasota, FL, 34243, United States; Open University, Walton Hall, Kents Hill, Milton-Keynes MK7 6AA, United Kingdom.
  • Mathura V; Roskamp Institute, 2040 Whitfield Ave, Sarasota, FL, 34243, United States.
  • Paris D; Roskamp Institute, 2040 Whitfield Ave, Sarasota, FL, 34243, United States; Open University, Walton Hall, Kents Hill, Milton-Keynes MK7 6AA, United Kingdom.
  • Crawford F; Roskamp Institute, 2040 Whitfield Ave, Sarasota, FL, 34243, United States; Open University, Walton Hall, Kents Hill, Milton-Keynes MK7 6AA, United Kingdom.
  • Mullan M; Roskamp Institute, 2040 Whitfield Ave, Sarasota, FL, 34243, United States; Open University, Walton Hall, Kents Hill, Milton-Keynes MK7 6AA, United Kingdom.
  • Ait-Ghezala G; Roskamp Institute, 2040 Whitfield Ave, Sarasota, FL, 34243, United States; Open University, Walton Hall, Kents Hill, Milton-Keynes MK7 6AA, United Kingdom.
Bioorg Chem ; 109: 104732, 2021 04.
Article en En | MEDLINE | ID: mdl-33639364
ABSTRACT
Candida rugosa lipase (CRL) is an enzyme commonly used in medicinal and biotechnological applications. Allosteric modulators of CRL could aid in modifying lipase-related diseases as well as improving biotechnological processes. Thus, a combinatorial approach of computational in-silico and high-throughput in-vitro screening was used to identify allosteric modulators of CRL. The screening of natural product libraries resulted in 132 compounds of which 53 were tested in-vitro. Subsequently, four inhibitors and three enhancers were identified of which rutin and cynaroside represented the strongest inhibitors of CRL activity (IC50 227 ± 26 µM and 446 ± 15 µM, respectively) and NP-008496 the strongest enhancer (EC50 425 ± 18 µM). All three compounds were predicted to bind the same allosteric site suggesting a common mechanism. Therefore, the present study demonstrated a reliable work-flow, identified an allosteric site of CRL and determined inhibitors and enhancers with numerous potential medical and biotechnological applications.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Productos Biológicos / Saccharomycetales / Inhibidores Enzimáticos / Lipasa Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Productos Biológicos / Saccharomycetales / Inhibidores Enzimáticos / Lipasa Idioma: En Año: 2021 Tipo del documento: Article